Syngene set for phase-2 trial of Covid oral tablet vaccine

Vaxart had started trials of its oral recombinant tablet vaccine in October last year. It enrolled 96 participants at four centres in the US. Participants included both-the untreated as well as previously vaccinated subjects.

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZRHLKcD
https://ift.tt/2N1PSvp

Post a Comment

Previous Post Next Post